MAKE AN APPOINTMENT

⚠ COVID-19 INFORMATION: Resources, Vaccine Information/Información sobre las vacunas

Lurie Children’s Home Specialties & ConditionsBronchopulmonary Dysplasia ProgramResearch on the Prevention and Management of BPD Bronchopulmonary Dysplasia Research Publications

Bronchopulmonary Dysplasia Research Publications

Learn more about our team's research:

Do Steroids Work to Prevent Lung Disease Among Premature Infants?

Cord Blood Test Might Help Predict Fatal Lung Disease in Preemies

Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension

Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia

Pulmonary hypertension in bronchopulmonary dysplasia

Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia

Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease

The impact of placental pathology discordance in multiple gestation pregnancies on bronchopulmonary dysplasia-associated pulmonary hypertension

Soluble Klotho, a biomarker and therapeutic strategy to reduce bronchopulmonary dysplasia and pulmonary hypertension in preterm infants

Umbilical Cord Blood Metabolomics Reveal Distinct Signatures of Dyslipidemia Prior to Bronchopulmonary Dysplasia and Pulmonary Hypertension

Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach

Placental Villous Vascularity Is Decreased in Premature Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension

Home Oxygen Use and 1-Year Readmission among Infants Born Preterm with Bronchopulmonary Dysplasia Discharged from Children's Hospital Neonatal Intensive Care Units

Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption

Exome sequencing identifies gene variants and networks associated with extreme respiratory outcomes following preterm birth

Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide

Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia

Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age

Therapies that enhance pulmonary vascular NO-signaling in the neonate

Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period

Postnatal growth restriction augments oxygen-induced pulmonary hypertension in a neonatal rat model of bronchopulmonary dysplasia

Mouse lung development and NOX1 induction during hyperoxia are developmentally regulated and mitochondrial ROS dependent

Disrupted pulmonary artery cyclic guanosine monophosphate signaling in mice with hyperoxia-induced pulmonary hypertension

Utility of echocardiography in predicting mortality in infants with severe bronchopulmonary dysplasia

Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study

Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice